The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000655347p
Ethics application status
Help: Ethics application status
Submitted, not yet approved
Date submitted
Help: Date submitted
12/04/2026
Date registered
Help: Date registered
2/06/2026
Date last updated
Help: Date last updated
2/06/2026
Date data sharing statement initially provided
Help: Data sharing statement date
2/06/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Advancing Care Through Injury Outcome Navigators
Scientific title
Evaluation of the effectiveness of a Trauma Patient Navigator model of care on patient-reported outcomes and experiences and clinical outcomes including costs, complication rates and engagement in follow-up care, for survivors of serious traumatic injury.
Additional trial identifiers [1] 317008 0
None
Universal Trial Number (UTN)
Trial acronym
ACTION
Related trial records

Health condition
Health condition(s) studied:
Major trauma 341495 0
Condition category
Condition code
Injuries and Accidents 337580 337580 0 0
Fractures
Injuries and Accidents 337581 337581 0 0
Other injuries and accidents
Public Health 337865 337865 0 0
Health service research

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Intervention
On enrolment into the study the enrolled patient and/or carer/significant other will receive the Trauma Patient Navigator (TPN) model of care intervention. Trauma patient navigation will incorporate a range of duties which will vary in composition dependent upon the patient/significant other health needs and requirements. Examples include (but are not limited to): early inpatient engagement with patients/families, communication and coordination with hospital staff and post discharge service providers including primary care, identification and knowledge of existing care pathways and their capabilities, integration of documentation with the patient electronic medical record, provision of up-to-date information and resources for patients and carers, undertaking needs assessments, and provision of education and psychosocial support.

The primary outcome measure of effectiveness will be the Visual Analogue Scale (VAS) item of the EQ-5D-5L, EQ-5D-Y-5L and EQ-TIPS (EQ VAS and EQ-5D) quality of life instrument measured at three different timepoints:
i. Baseline (self-reported pre-injury)
ii. On discharge from acute care at the major trauma centre
iii. At 6-months from the date of enrolment.

Who delivers it and their relevant expertise
A Trauma Patient Navigator will be employed at each of the individual trauma centre/health service (n=8). A generic role description for a Trauma Patient Navigator has been informed and developed by previous research undertaken by the study team prior to the commencement of the stepped-wedge RCT.
The Principal Investigator at each site (trauma centre) will be provided with the generic Trauma Patient Navigator role description prior to commencement of the SW-RCT. Individual health services/trauma centre/PI will be responsible for the provision of training and education required by the Trauma Patient Navigator; duration and frequency of training will therefore vary and be aligned with the individual health service requirements.

How it is delivered (e.g. face to face, online, group, individual)
Trauma patient navigation will incorporate a range of duties which will vary in composition dependent upon the patient/significant other health needs and requirements. As such, it is anticipated delivery of the Trauma Patient Navigator model of care will encompass a range of modalities including face to face, phone, online.

How often and for how long (e.g. 8 x 1 hour sessions over 8 weeks)
The level of engagement of participants with the Trauma Patient Navigator model of care will be dependent upon the patient/significant other health needs and requirements. However, primary outcome data will be collected at 3 distinct timepoints - on enrolment into the study, on discharge from acute care and at 6-months post enrolment. Each participant will received the Trauma Patient Navigator model of care for 6-months post enrolment.

Where it is delivered (e.g. clinic, participant's home, school)
The Trauma Patient Navigator model of care will commence during the participants index admission and continue for 6-months. The model of care will cover the transition period from acute care to home. As such the model of care will cover a range of environments including acute care, clinic, participants home.

Adherence (e.g. reminders, monitoring)
A parallel Process Evaluation will occur to evaluate the feasibility and acceptability of the Trauma Patient Navigator Intervention. Routine Trauma Patient Navigator activity data will be collected to quantify the nature and intensity of the intervention.
Intervention code [1] 333768 0
Treatment: Other
Intervention code [2] 333769 0
Rehabilitation
Description of the comparator or control
What is the comparator
Standard care

The ACTION study is a stepped-wedge randomised controlled trial (RCT). Each trauma centre will be a single cluster. Each cluster will commence at two-monthly intervals according to the randomisation sequence. Each cluster (trauma centre) will include a 6-month control phase prior to the implementation of the TPN intervention. The intervention phase (TPN) will extend for 12-months to allow all patients to receive the TPN model of care for 6-months.

The trauma centre is the unit of randomisation. At the point where the trauma centre crosses over from the control phase (standard care) to the intervention phase (TPN phase), the TPN model of care will be provided in addition to standard care to all eligible patients, carers/significant others and parents/guardians (as defined by the study inclusion/exclusion criteria). Participants who meet the inclusion criteria and consent to participate in the study will receive the TPN model of care which will be adjunct to the standard care received. Patients, carers/significant others and parents/guardians who are not eligible to participate or decline participation will receive standard care.

Who delivers it and their relevant expertise
Health Services

How it is delivered (e.g. face to face, online, group, individual)
As per standard care

How often and for how long (e.g. 8 x 1 hour sessions over 8 weeks)
As per standard care

Where it is delivered (e.g. clinic, participant's home, school)
As per standard care

Where the comparison data come from (e.g. medical records, previous studies)
The primary outcome measure of effectiveness will be the Visual Analogue Scale (VAS) item of the EQ-5D-5L, EQ-5D-Y-5L and EQ-TIPS (EQ VAS and EQ-5D) quality of life instrument measured at three different timepoints:
i. Baseline (self-reported pre-injury)
ii. On discharge from acute care at the major trauma centre
iii. At 6-months from the date of enrolment.

Time period when the historical data were collected
Six months prior to intervention commencing
Control group
Active

Outcomes
Primary outcome [1] 345068 0
The primary outcome measure of effectiveness participants health related quality of life.
Timepoint [1] 345068 0
measured at three different timepoints: i. Baseline (self-reported pre-injury) ii. On discharge from acute care at the major trauma centre iii. At 6-months from the date of enrolment.
Secondary outcome [1] 460347 0
Patient satisfaction of the Trauma Patient Navigator model of care
Timepoint [1] 460347 0
o Baseline (self-reported pre-injury) o Discharge from acute care at the trauma centre o At 6-months following enrolment into the study.
Secondary outcome [2] 461291 0
Carer/Significant Other satisfaction with the Trauma Patient Navigator model of care
Timepoint [2] 461291 0
o Baseline (self-reported pre-injury) o Discharge from acute care at the trauma centre o At 6-months following enrolment into the study.
Secondary outcome [3] 461292 0
Parent or Guardian satisfaction with the Trauma Patient Navigator model of care
Timepoint [3] 461292 0
o Baseline (self-reported pre-injury) o Discharge from acute care at the trauma centre o At 6-months following enrolment into the study.
Secondary outcome [4] 461293 0
Patient experience of the Trauma Patient Navigator model of care
Timepoint [4] 461293 0
o Baseline (self-reported pre-injury) o Discharge from acute care at the trauma centre o At 6-months following enrolment into the study.
Secondary outcome [5] 461884 0
Carer or significant other experience of the Trauma Patient Navigator model of care
Timepoint [5] 461884 0
- Baseline (self reported pre-injury) - Discharge from acute care at the trauma centre - At 6-months following enrolment into the study
Secondary outcome [6] 461885 0
Parent/Guardian experience of the Trauma Patient Navigator model of care
Timepoint [6] 461885 0
- Baseline (self reported pre-injury) - Discharge from acute care at the trauma centre - At 6-months following enrolment into the study
Secondary outcome [7] 461886 0
Patient self efficacy
Timepoint [7] 461886 0
- Baseline (self-reported pre-injury) - Discharge from acute care at the trauma centre - At 6-months folllowing enrolment into the study
Secondary outcome [8] 461887 0
Carer or significant other
Timepoint [8] 461887 0
- Baseline - Discharge from acute care at the trauma centre - At 6-months following enrolment into the study
Secondary outcome [9] 461892 0
Parent or Guardian Self Efficacy
Timepoint [9] 461892 0
- Baseline - Discharge from acute care at the trauma centre - At 6-months following enrolment into the study
Secondary outcome [10] 461893 0
Patient - Health Service Utilisation
Timepoint [10] 461893 0
During hospital admission; from acute care discharge up to 6-months following enrolment into the study
Secondary outcome [11] 461894 0
Carer/Significant Other Healthcare Utilisation
Timepoint [11] 461894 0
During hospital admission; from acute care discharge up to 6-months following enrolment into the study
Secondary outcome [12] 461895 0
Parent and Guardian
Timepoint [12] 461895 0
During hospital admission; from acute care discharge up to 6-months following enrolment into the study

Eligibility
Key inclusion criteria
- Estimated Injury Severity Score (ISS) >12 on hospital admission OR injuries to multiple body regions (e.g. head, chest, abdomen, pelvis, long bones, spine) OR Traumatic Brain Injury (TBI) patients with post resuscitation Glasgow Coma Scale (GCS) equal to or grater than 6.
- Planned discharge to home or an inpatient rehabilitation centre.
Minimum age
No limit
Maximum age
80 Years
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Patients will not be eligible for inclusion if any of the following criteria are met:
- Patients with predominantly burn or spinal cord injury.
- Patients aged 80 years or older.
- Patients who discharge from acute care against medical advice.
- Patients who are discharged from acute care to any of the following:
o Aged care facilities
o Palliative care
o Mental health facilities
o Correctional facility

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation is not concealed
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
stepped-wedge RCT
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Other
Other design features
stepped-wedge RCT - Each trauma centre will be a single cluster. Each cluster will commence at 2-monthly intervals according to the randomisation sequence. All clusters will include a 6-month control phase (usual care) prior to the implementation of the TPN intervention. The TPN intervention phase will extend for 12-months for the purposes of this trial.
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis
An intention-to-treat approach will be used to analyse the data from the balanced staircase stepped wedge RCT. Patient characteristics will be summarised for the pre- and post- intervention periods overall and by the participating centres. Routinely collected data will be obtained from the centre’s trauma registry and administrative data collections.

Descriptive data analysis will include frequencies and percentages for categorical variables and mean and standard deviation or median and interquartile range for continuous variables. Exploratory data analysis will include the appropriate data and variable distribution checks, evaluation of cluster trajectories, estimation of the intraclass correlation (ICC) and cluster autocorrelation coefficient (CAC). The cluster heterogeneity and covariate balance and required tests will be performed. Given the design of the study and nature of the primary outcomes, the data structure will be checked (e.g. verifying the monotone crossover pattern). The degree and mechanisms of missingness will be assessed and quantified (e.g. overall and per cluster), with the appropriate method of imputation used. Mixed effects linear regression will be used to analyse the primary effectiveness outcome with centre and time as random effects and relevant adjustment for other potential confounders considered. A systematic approach will be used for the development of the model and appropriate postestimation diagnostics will be implemented. The relevant sensitivity analysis will be performed to test the robustness of findings (e.g., children versus adults, CAC variation).

A full statistical analysis plan will be finalised prior to data lock.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW,QLD,SA,TAS,WA,VIC
Recruitment hospital [1] 29477 0
The Alfred - Melbourne
Recruitment hospital [2] 29478 0
John Hunter Hospital - New Lambton
Recruitment hospital [3] 29479 0
The Royal Adelaide Hospital - Adelaide
Recruitment hospital [4] 29480 0
Royal Melbourne Hospital - City campus - Parkville
Recruitment hospital [5] 29481 0
The Royal Childrens Hospital - Parkville
Recruitment hospital [6] 29482 0
Royal Perth Hospital - Perth
Recruitment hospital [7] 29483 0
Royal Hobart Hospital - Hobart
Recruitment hospital [8] 29484 0
Royal Brisbane & Womens Hospital - Herston
Recruitment postcode(s) [1] 45795 0
3004 - Melbourne
Recruitment postcode(s) [2] 45796 0
2305 - New Lambton
Recruitment postcode(s) [3] 45797 0
5000 - Adelaide
Recruitment postcode(s) [4] 45798 0
3050 - Parkville
Recruitment postcode(s) [5] 45799 0
6000 - Perth
Recruitment postcode(s) [6] 45800 0
7000 - Hobart
Recruitment postcode(s) [7] 45801 0
4029 - Herston

Funding & Sponsors
Funding source category [1] 321606 0
Government body
Name [1] 321606 0
Department of Health, Disability and Aging - Medical Research Future Fund - Preventative and Public Health Research
Country [1] 321606 0
Australia
Primary sponsor type
University
Name
Monash University
Address
Country
Australia
Secondary sponsor category [1] 324415 0
None
Name [1] 324415 0
Address [1] 324415 0
Country [1] 324415 0

Ethics approval
Ethics application status
Submitted, not yet approved
Ethics committee name [1] 320132 0
Alfred Hospital Ethics Committee
Ethics committee address [1] 320132 0
Ethics committee country [1] 320132 0
Australia
Date submitted for ethics approval [1] 320132 0
06/05/2026
Approval date [1] 320132 0
Ethics approval number [1] 320132 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 149542 0
Prof Belinda Gabbe
Address 149542 0
Monash University, 553 St Kilda Road, Melbourne Victoria, 3044
Country 149542 0
Australia
Phone 149542 0
+61 3 9903 0951
Fax 149542 0
Email 149542 0
Contact person for public queries
Name 149543 0
Elizabeth Wake
Address 149543 0
Monash University, 553 St Kilda Road, Melbourne Victoria, 3044
Country 149543 0
Australia
Phone 149543 0
+61 449158244
Fax 149543 0
Email 149543 0
Contact person for scientific queries
Name 149544 0
Belinda Gabbe
Address 149544 0
Monash University, 553 St Kilda Road, Melbourne Victoria, 3044
Country 149544 0
Australia
Phone 149544 0
+61 3 9903 0951
Fax 149544 0
Email 149544 0

Data sharing statement
Will the study consider sharing individual participant data?
No
No IPD sharing reason/comment: as per HREC



What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.